Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD) Michael A. Nalesnik OriginalPaper Pages: 325 - 342
The molecular genetics of post-transplantation lymphoproliferative disorders Daniel M. Knowles OriginalPaper Pages: 357 - 373
Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders Tanzina HaqueDorothy H. Crawford OriginalPaper Pages: 375 - 387
Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders Martin RoweGerald NiedobitekLawrence S. Young OriginalPaper Pages: 389 - 403
Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD Giovanna TosatoJulie Teruya-FeldsteinElaine S. Jaffe OriginalPaper Pages: 405 - 423
Interferon-α and its effects on post-transplant lymphoproliferative disorders Albert Faro OriginalPaper Pages: 425 - 436
The antiviral prophylaxis of post-transplant lymphoproliferative disorder C. L. Davis OriginalPaper Pages: 437 - 453
Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts Richard J. O'ReillyTrudy N. SmallLidia Koulova OriginalPaper Pages: 455 - 491